| For: | Fuente RAL, Gutiérrez ML, Garcia-Samaniego J, Fernández-Rodriguez C, Lledó JL, Castellano G. Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol 2011; 17(12): 1543-1548 [PMID: 21472118 DOI: 10.3748/wjg.v17.i12.1543] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i12/1543.htm |
| Number | Citing Articles |
| 1 |
Abdulrasheed Usman, Bukhari Isah Shuaib, Bolanle O. P. Musa, Sani Awwal, Sunday Akogwu. Seroprevalence of Occult Hepatitis B Virus Infection Using Anti-HBc and Nucleic Acid Amplification (HBV DNA) Technique in a Resource-Limited Setting: a Systematic Review and Meta-Analysis of Nigerian Literature. SN Comprehensive Clinical Medicine 2022; 5(1) doi: 10.1007/s42399-022-01359-y
|
| 2 |
Ajeet Singh Bhadoria, Chandan Kumar Kedarisetty, Chhagan Bihari, Guresh Kumar, Ankur Jindal, Ankit Bhardwaj, Varsha Shasthry, Jaya Benjamin, Manoj Kumar Sharma, Shiv Kumar Sarin. Positive familial history for metabolic traits predisposes to early and more severe alcoholic cirrhosis: A cross‐sectional study. Liver International 2019; 39(1) doi: 10.1111/liv.13958
|
| 3 |
Ziba Shabani, Masomeh Bagheri, Mohammad Zare-Bidaki, Gholamhossein Hassanshahi, Mohammad Kazemi Arababadi, Mozafar Mohammadi Nejad, Derek Kennedy. NK cells in hepatitis B virus infection: a potent target for immunotherapy. Archives of Virology 2014; 159(7) doi: 10.1007/s00705-013-1965-3
|
| 4 |
Masoud Karimi‐Googheri, Hamid Daneshvar, Reza Nosratabadi, Mohammad Zare‐Bidaki, Gholamhossein Hassanshahi, Maryam Ebrahim, Mohammad Kazemi Arababadi, Derek Kennedy. Important roles played by TGF‐β in hepatitis B infection. Journal of Medical Virology 2014; 86(1) doi: 10.1002/jmv.23727
|
| 5 |
Mehdi Zobeiri. Occult Hepatitis B: Clinical Viewpoint and Management. Hepatitis Research and Treatment 2013; 2013 doi: 10.1155/2013/259148
|
| 6 |
Edina Amponsah‐Dacosta, Selokela G. Selabe, Maphahlaganye J. Mphahlele. Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co‐infected patients. Journal of Medical Virology 2018; 90(2) doi: 10.1002/jmv.24956
|
| 7 |
Jin-Wook Kim. Occult hepatitis B virus infection: clearance or disguise?. Clinical and Molecular Hepatology 2014; 20(3) doi: 10.3350/cmh.2014.20.3.249
|
| 8 |
Carlos Mario Jaramillo, Fernando de La Hoz, Alexandra Porras, Diana di Filippo, Luz Angela Choconta-Piraquive, Edra Payares, Neyla Montes, Maria-Cristina Navas, Pierre Roques. Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia. PLOS ONE 2017; 12(10) doi: 10.1371/journal.pone.0181643
|
| 9 |
Noor A. Kazim, Kareem M. Lilo, Shaima R. Ibraheem, Yaqoob A. Saleh, Sally B. Shabeeb. EVALUATION OF SEROLOGICAL SCREENING AND PCR-AMPLIFICATION OF HEPATITIS B VIRUS DNA AMONG IRAQI BLOOD DONORS. Wiadomości Lekarskie 2022; 75(12) doi: 10.36740/WLek202212104
|
| 10 |
Ling Li, Rui Wang, Jin Guo, Liu He, Zhengmin Liu, Qianqian Qin, Jing Zhang, Shuo Wu, Liqin Huang, Hongwei Ge, Zhong Liu. Suggested blood donor deferral strategy regarding hepatitis B infections in China. Transfusion Medicine 2024; 34(2) doi: 10.1111/tme.13030
|
| 11 |
Shashi A. Gujar, Patricia M. Mulrooney-Cousins, Tomasz I. Michalak. Repeated Exposure to Trace Amounts of Woodchuck Hepadnavirus Induces Molecularly Evident Infection and Virus-Specific T Cell Response in the Absence of Serological Infection Markers and Hepatitis. Journal of Virology 2013; 87(2) doi: 10.1128/JVI.01363-12
|
| 12 |
Mohammad Kazemi Arababadi, Mohammad Zare Bidaki, Derek Kennedy. IL-17A in hepatitis B infection: friend or foe?. Archives of Virology 2014; 159(8) doi: 10.1007/s00705-014-2002-x
|
| 13 |
Félix P.D. Pinto, Orlando C. Ferreira Jr., Daniele B. Olmedo, Patrícia M. Precioso, Fernanda R.S. Barquette, Magda C. Castilho, Suely G.C. Silva, Luís Cristóvão Pôrto. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study. Annals of Hepatology 2015; 14(6) doi: 10.5604/16652681.1171756
|
| 14 |
Ebrahim Eskandari, Malihe Metanat, Elham Pahlevani, Tooba Nakhzari-Khodakheir. Association between TGFβ1 polymorphisms and chronic hepatitis B infection in an Iranian population. Revista da Sociedade Brasileira de Medicina Tropical 2017; 50(3) doi: 10.1590/0037-8682-0266-2016
|
| 15 |
Rasoul Estakhri, Mohamad Ali Somi, Ali Taban, Mohamad Goldust. WITHDRAWN: Evaluation of correlation between serum immunoglobulin levels and extent of hepatic fibrosis in patients with chronic B and C hepatitis. Pathology - Research and Practice 2013; doi: 10.1016/j.prp.2013.05.006
|
| 16 |
Amanda Abramson, Alan Menter, Robert Perrillo. Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management. Journal of the American Academy of Dermatology 2012; 67(6) doi: 10.1016/j.jaad.2012.04.036
|
| 17 |
Francisca Sosa-Jurado, Daniel Meléndez-Mena, Nora H. Rosas-Murrieta, Belinda Guzmán-Flores, Miguel A. Mendoza-Torres, Roberto Barcenas-Villalobos, Luis Márquez-Domínguez, Paulina Cortés-Hernández, Julio Reyes-Leyva, Verónica Vallejo-Ruiz, Gerardo Santos-López, Isabelle Chemin. Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients. PLOS ONE 2018; 13(10) doi: 10.1371/journal.pone.0205356
|
| 18 |
Amadin A. Olotu, Adesola O. Oyelese, Lateef Salawu, Rosemary A. Audu, Azuka P. Okwuraiwe, Aaron O. Aboderin. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virology Journal 2016; 13(1) doi: 10.1186/s12985-016-0533-3
|
| 19 |
Ajeet S. Bhadoria, Chandan K. Kedarisetty, Chhagan Bihari, Guresh Kumar, Ankur Jindal, Ankit Bhardwaj, Varsha Shasthry, Tanmay Vyas, Jaya Benjamin, Shvetank Sharma, Manoj K. Sharma, Shiv K. Sarin. Impact of family history of metabolic traits on severity of non‐alcoholic steatohepatitis related cirrhosis: A cross‐sectional study. Liver International 2017; 37(9) doi: 10.1111/liv.13396
|
| 20 |
Jaime Morales-Romero, Gustavo Vargas, Rebeca García-Román. Occult HBV Infection: A Faceless Enemy in Liver Cancer Development. Viruses 2014; 6(4) doi: 10.3390/v6041590
|